OncoClew
|
Year Established:
2021 |
|
|
Website:
oncoclew.com |
|
|
Headquarters:
Seongdong-gu, Seoul, KR |
|
|
Company Type:
New Startup (0-1M TTM Revenue) |
|
|
Completed Requests:
1 |
|
|
Open Requests:
1 |
Oncoclew CO.,LTD is best partner for cancer research and developing cancer therapeutics.
Our core technologies are as follows.
1. TDEA (tumoroid based drug efficacy testing assay) – In tumoroid biobank, the test group can be selected based on the types of cancer origins, genotypes, and phenotypes desired by sponsor, and drug efficacy assay is carried out by expert research team.
2. TDRA (tumoroid drug response assay) – a next-generation anti-cancer drug response assay based on patient-derived tumoroids.
3. TBDD (tumoroid & big-data based drug development) – Drug efficacy assay and hit finding, biomarker identification, finding new targets and drug repositionsing, patient segmentation expansion.
| Site | Badges | |
|---|---|---|
| Oncoclew CO.,LTD 31, Ttukseom-ro 1-gil Seongdong-gu, Seoul, 04778 South Korea | ||
| Oncoclew CO.,LTD 31, Ttukseom-ro 1-gil Seongdong-gu, Seoul, 04778 South Korea | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.